InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Siegel Jolie, Directeur Juridique. Officer active across 1 company, notably C4 Therapeutics, Inc.. Aggregated, 11 disclosures have been logged. Activity tracked since 29 July 2021. The latest transaction was disclosed on 13 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Siegel Jolie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
2,135 股@ US$3.202.8% 占其流量Common StockSEC:0001662579-25-000020:0
3,750 股Common StockSEC:0001662579-24-000101:0
2,250 股Common StockSEC:0001662579-24-000079:0
1,735 股@ US$6.534.5% 占其流量Common StockSEC:0001662579-24-000018:0
2,250 股Common StockSEC:0001662579-23-000085:0
20,000 股0Common StockSEC:0001662579-23-000038:0
3,750 股Common StockSEC:0001662579-23-000019:0
1,102 股@ US$7.015.6% 占其流量Common StockSEC:0001209191-22-036718:0
3,750 股Common StockSEC:0001209191-22-032515:0
12,500 股@ US$4.9840.7% 占其流量Common StockSEC:0001209191-21-055881:0
12,500 股@ US$4.9840.5% 占其流量Common StockSEC:0001209191-21-049120:0
11 条申报中的 11 条
About Siegel Jolie
Siegel Jolie is Director Juridique and Chief Legal Officer at C4 Therapeutics, Inc. He has 11 filings in total, and, within the sampled recent filings, the period runs from 2021-08-02 to 2025-02-18, with a modal transaction nature of option exercise. The buy and sell amounts indicated for this sample are 0 and 0.
